nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—skin of body—breast cancer	0.0195	0.129	CbGeAlD
Icosapent ethyl—DGAT1—endometrium—breast cancer	0.0184	0.122	CbGeAlD
Icosapent ethyl—DGAT1—pituitary gland—breast cancer	0.0167	0.11	CbGeAlD
Icosapent ethyl—DGAT1—adipose tissue—breast cancer	0.0166	0.11	CbGeAlD
Icosapent ethyl—DGAT1—female reproductive system—breast cancer	0.0153	0.101	CbGeAlD
Icosapent ethyl—DGAT1—adrenal gland—breast cancer	0.0149	0.0983	CbGeAlD
Icosapent ethyl—DGAT1—bone marrow—breast cancer	0.0144	0.0951	CbGeAlD
Icosapent ethyl—DGAT1—female gonad—breast cancer	0.0139	0.0916	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—ALDH1A1—breast cancer	0.0137	0.0607	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RXRB—breast cancer	0.0131	0.0582	CbGpPWpGaD
Icosapent ethyl—DGAT1—endocrine gland—breast cancer	0.0129	0.0852	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—SULT1A1—breast cancer	0.0107	0.0476	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RARB—breast cancer	0.00947	0.0421	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—SYNJ2—breast cancer	0.00897	0.0399	CbGpPWpGaD
Icosapent ethyl—DGAT1—lymph node—breast cancer	0.00892	0.0589	CbGeAlD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—HADHB—breast cancer	0.00807	0.0359	CbGpPWpGaD
Icosapent ethyl—DGAT1—Triglyceride Biosynthesis—FASN—breast cancer	0.00744	0.0331	CbGpPWpGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—FABP7—breast cancer	0.00709	0.336	CrCbGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—HADHB—breast cancer	0.00563	0.025	CbGpPWpGaD
Icosapent ethyl—Icosapent—FABP7—breast cancer	0.00557	0.264	CrCbGaD
Icosapent ethyl—Alpha-Linolenic Acid—FABP7—breast cancer	0.00544	0.258	CrCbGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ANGPTL4—breast cancer	0.0048	0.0213	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ESRRA—breast cancer	0.0048	0.0213	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—HADHB—breast cancer	0.00455	0.0202	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—ACHE—breast cancer	0.00452	0.0201	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—FHL2—breast cancer	0.00416	0.0185	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—BCHE—breast cancer	0.00394	0.0175	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1B—breast cancer	0.00375	0.0167	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—ACHE—breast cancer	0.00316	0.014	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	0.00289	0.0128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—breast cancer	0.00289	0.0128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—PLA2G4A—breast cancer	0.00288	0.0128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA3—breast cancer	0.00276	0.0123	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—BCHE—breast cancer	0.00275	0.0122	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1A—breast cancer	0.00268	0.0119	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA2—breast cancer	0.0023	0.0102	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—breast cancer	0.00223	0.00992	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	0.00211	0.00936	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PLA2G4A—breast cancer	0.00201	0.00894	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA1—breast cancer	0.00194	0.00862	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	0.00191	0.0085	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	0.00191	0.0085	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HADHB—breast cancer	0.00181	0.00806	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—FHL2—breast cancer	0.00166	0.00737	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—breast cancer	0.00163	0.00723	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	0.00154	0.00685	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—breast cancer	0.00154	0.00685	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CG—breast cancer	0.00149	0.00664	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	0.00149	0.00664	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GPX2—breast cancer	0.00137	0.00611	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GPX4—breast cancer	0.00136	0.00603	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—IDH1—breast cancer	0.00133	0.00589	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CD—breast cancer	0.00131	0.00583	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SYNJ2—breast cancer	0.00129	0.00572	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NDUFS3—breast cancer	0.0012	0.00531	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—MED12—breast cancer	0.00115	0.00511	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CB—breast cancer	0.00114	0.00509	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CHST9—breast cancer	0.00112	0.005	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	0.0011	0.00488	CbGpPWpGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS1—breast cancer	0.00107	0.0509	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	0.00107	0.00475	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—COX11—breast cancer	0.00107	0.00474	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	0.00105	0.00466	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	0.00102	0.00452	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PTEN—breast cancer	0.000989	0.00439	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CDA—breast cancer	0.000975	0.00433	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SHMT1—breast cancer	0.000975	0.00433	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	0.000962	0.00428	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	0.000953	0.00423	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLCO1B1—breast cancer	0.000938	0.00417	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC2A5—breast cancer	0.000938	0.00417	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	0.000917	0.00408	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APRT—breast cancer	0.000906	0.00403	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—FASN—breast cancer	0.000889	0.00395	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	0.000886	0.00394	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ANGPTL4—breast cancer	0.000852	0.00379	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ESRRA—breast cancer	0.000852	0.00379	CbGpPWpGaD
Icosapent ethyl—Icosapent—PTGS1—breast cancer	0.000843	0.0399	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	0.00081	0.0036	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GPI—breast cancer	0.000808	0.00359	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HADHB—breast cancer	0.000808	0.00359	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	0.000773	0.00343	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALDH1A1—breast cancer	0.00077	0.00342	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALDH7A1—breast cancer	0.00077	0.00342	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	0.000761	0.00338	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ADSL—breast cancer	0.000739	0.00328	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PHGDH—breast cancer	0.000739	0.00328	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UMPS—breast cancer	0.000739	0.00328	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—FHL2—breast cancer	0.000739	0.00328	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NME1—breast cancer	0.000739	0.00328	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HPSE—breast cancer	0.000724	0.00322	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—BRIP1—breast cancer	0.000724	0.00322	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LDHB—breast cancer	0.000724	0.00322	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CA—breast cancer	0.000698	0.0031	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTA3—breast cancer	0.000687	0.00305	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HMMR—breast cancer	0.000687	0.00305	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCC1—breast cancer	0.000687	0.00305	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPARGC1B—breast cancer	0.000665	0.00296	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	0.000647	0.00288	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	0.000647	0.00288	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTA4—breast cancer	0.000628	0.00279	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CA9—breast cancer	0.000628	0.00279	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	0.00062	0.00276	CbGpPWpGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—breast cancer	0.000614	0.0291	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	0.000614	0.00273	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GPX2—breast cancer	0.000612	0.00272	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTA2—breast cancer	0.000612	0.00272	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GPX4—breast cancer	0.000605	0.00269	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SULT1A1—breast cancer	0.000605	0.00269	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—IDH1—breast cancer	0.00059	0.00262	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTA1—breast cancer	0.00059	0.00262	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NAT2—breast cancer	0.000584	0.00259	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.000528	0.00235	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—DPYD—breast cancer	0.000512	0.00228	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MED12—breast cancer	0.000512	0.00228	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALDOA—breast cancer	0.000504	0.00224	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOA3—breast cancer	0.000489	0.00217	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC2A2—breast cancer	0.000486	0.00216	CbGpPWpGaD
Icosapent ethyl—Icosapent—PTGS2—breast cancer	0.000482	0.0228	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000481	0.00214	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CPT1A—breast cancer	0.000476	0.00212	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCG2—breast cancer	0.000476	0.00212	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MTR—breast cancer	0.000476	0.00212	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HPGDS—breast cancer	0.000467	0.00207	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HBA1—breast cancer	0.000464	0.00206	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTT1—breast cancer	0.000453	0.00201	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ACHE—breast cancer	0.000453	0.00201	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP17A1—breast cancer	0.000429	0.0019	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PTGS1—breast cancer	0.000424	0.00189	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ENO1—breast cancer	0.000424	0.00189	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000423	0.00188	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000417	0.00185	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP2D6—breast cancer	0.000416	0.00185	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOA2—breast cancer	0.000408	0.00181	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—FASN—breast cancer	0.000396	0.00176	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—BCHE—breast cancer	0.000394	0.00175	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC5A5—breast cancer	0.00039	0.00173	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NQO1—breast cancer	0.000376	0.00167	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC2A1—breast cancer	0.000376	0.00167	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000368	0.00164	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP3A4—breast cancer	0.000367	0.00163	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000365	0.00162	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP1B1—breast cancer	0.000361	0.0016	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HSP90AA1—breast cancer	0.000354	0.00157	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOA1—breast cancer	0.000344	0.00153	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—STK11—breast cancer	0.000339	0.00151	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP19A1—breast cancer	0.000339	0.00151	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000318	0.00141	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—COMT—breast cancer	0.000315	0.0014	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTP1—breast cancer	0.000314	0.00139	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HMOX1—breast cancer	0.000309	0.00138	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ITPR1—breast cancer	0.000309	0.00137	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCB1—breast cancer	0.000297	0.00132	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TYMS—breast cancer	0.000292	0.0013	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTM1—breast cancer	0.000288	0.00128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PLA2G4A—breast cancer	0.000288	0.00128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOR1—breast cancer	0.000288	0.00128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GPX1—breast cancer	0.000276	0.00123	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP1A1—breast cancer	0.000273	0.00121	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ERCC2—breast cancer	0.000271	0.0012	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MTHFR—breast cancer	0.000255	0.00113	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CAV1—breast cancer	0.000235	0.00104	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.000225	0.000998	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CG—breast cancer	0.000214	0.000952	CbGpPWpGaD
Icosapent ethyl—Vomiting—Vinorelbine—breast cancer	0.000206	0.000341	CcSEcCtD
Icosapent ethyl—Body temperature increased—Gemcitabine—breast cancer	0.000205	0.000341	CcSEcCtD
Icosapent ethyl—Dizziness—Thiotepa—breast cancer	0.000204	0.000339	CcSEcCtD
Icosapent ethyl—Rash—Vinorelbine—breast cancer	0.000204	0.000338	CcSEcCtD
Icosapent ethyl—Dermatitis—Vinorelbine—breast cancer	0.000204	0.000338	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—breast cancer	0.000204	0.000338	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Capecitabine—breast cancer	0.000203	0.000337	CcSEcCtD
Icosapent ethyl—Syncope—Docetaxel—breast cancer	0.000203	0.000336	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—breast cancer	0.000202	0.000336	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—breast cancer	0.000202	0.000336	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—breast cancer	0.000202	0.000336	CcSEcCtD
Icosapent ethyl—Body temperature increased—Fluorouracil—breast cancer	0.000202	0.000335	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—breast cancer	0.0002	0.000332	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Docetaxel—breast cancer	0.000199	0.00033	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—breast cancer	0.000198	0.000329	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000198	0.000329	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—breast cancer	0.000197	0.000327	CcSEcCtD
Icosapent ethyl—Malaise—Capecitabine—breast cancer	0.000197	0.000327	CcSEcCtD
Icosapent ethyl—Cough—Docetaxel—breast cancer	0.000197	0.000327	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—breast cancer	0.000197	0.000327	CcSEcCtD
Icosapent ethyl—Insomnia—Paclitaxel—breast cancer	0.000197	0.000327	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—breast cancer	0.000196	0.000326	CcSEcCtD
Icosapent ethyl—Vertigo—Capecitabine—breast cancer	0.000196	0.000326	CcSEcCtD
Icosapent ethyl—Vomiting—Thiotepa—breast cancer	0.000196	0.000326	CcSEcCtD
Icosapent ethyl—Syncope—Capecitabine—breast cancer	0.000196	0.000326	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—breast cancer	0.000196	0.000326	CcSEcCtD
Icosapent ethyl—Hypertension—Docetaxel—breast cancer	0.000195	0.000324	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—breast cancer	0.000195	0.000324	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—breast cancer	0.000195	0.000324	CcSEcCtD
Icosapent ethyl—Rash—Thiotepa—breast cancer	0.000195	0.000323	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—breast cancer	0.000195	0.000323	CcSEcCtD
Icosapent ethyl—Dermatitis—Thiotepa—breast cancer	0.000195	0.000323	CcSEcCtD
Icosapent ethyl—Dyspnoea—Paclitaxel—breast cancer	0.000194	0.000322	CcSEcCtD
Icosapent ethyl—Arthralgia—Docetaxel—breast cancer	0.000192	0.000319	CcSEcCtD
Icosapent ethyl—Chest pain—Docetaxel—breast cancer	0.000192	0.000319	CcSEcCtD
Icosapent ethyl—Myalgia—Docetaxel—breast cancer	0.000192	0.000319	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Capecitabine—breast cancer	0.000192	0.000319	CcSEcCtD
Icosapent ethyl—Dyspepsia—Paclitaxel—breast cancer	0.000191	0.000318	CcSEcCtD
Icosapent ethyl—Asthenia—Mitoxantrone—breast cancer	0.000191	0.000318	CcSEcCtD
Icosapent ethyl—Asthenia—Irinotecan—breast cancer	0.000191	0.000318	CcSEcCtD
Icosapent ethyl—Cough—Capecitabine—breast cancer	0.000191	0.000317	CcSEcCtD
Icosapent ethyl—Decreased appetite—Paclitaxel—breast cancer	0.000189	0.000314	CcSEcCtD
Icosapent ethyl—Hypertension—Capecitabine—breast cancer	0.000189	0.000313	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CD—breast cancer	0.000188	0.000837	CbGpPWpGaD
Icosapent ethyl—Dry mouth—Docetaxel—breast cancer	0.000188	0.000312	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000188	0.000312	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—breast cancer	0.000187	0.00031	CcSEcCtD
Icosapent ethyl—Asthenia—Gemcitabine—breast cancer	0.000186	0.000309	CcSEcCtD
Icosapent ethyl—Arthralgia—Capecitabine—breast cancer	0.000186	0.000309	CcSEcCtD
Icosapent ethyl—Myalgia—Capecitabine—breast cancer	0.000186	0.000309	CcSEcCtD
Icosapent ethyl—Chest pain—Capecitabine—breast cancer	0.000186	0.000309	CcSEcCtD
Icosapent ethyl—Pain—Paclitaxel—breast cancer	0.000186	0.000309	CcSEcCtD
Icosapent ethyl—Constipation—Paclitaxel—breast cancer	0.000186	0.000309	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ALB—breast cancer	0.000186	0.000826	CbGpPWpGaD
Icosapent ethyl—Pharyngitis—Methotrexate—breast cancer	0.000186	0.000308	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Docetaxel—breast cancer	0.000184	0.000306	CcSEcCtD
Icosapent ethyl—Oedema—Docetaxel—breast cancer	0.000184	0.000306	CcSEcCtD
Icosapent ethyl—Discomfort—Capecitabine—breast cancer	0.000184	0.000305	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—breast cancer	0.000184	0.000305	CcSEcCtD
Icosapent ethyl—Pruritus—Gemcitabine—breast cancer	0.000184	0.000305	CcSEcCtD
Icosapent ethyl—Infection—Docetaxel—breast cancer	0.000183	0.000304	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—breast cancer	0.000183	0.000304	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—breast cancer	0.000183	0.000303	CcSEcCtD
Icosapent ethyl—Dry mouth—Capecitabine—breast cancer	0.000182	0.000302	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—breast cancer	0.000181	0.000301	CcSEcCtD
Icosapent ethyl—Shock—Docetaxel—breast cancer	0.000181	0.000301	CcSEcCtD
Icosapent ethyl—Pruritus—Fluorouracil—breast cancer	0.000181	0.0003	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—breast cancer	0.00018	0.000299	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—breast cancer	0.00018	0.000299	CcSEcCtD
Icosapent ethyl—Tachycardia—Docetaxel—breast cancer	0.00018	0.000299	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Paclitaxel—breast cancer	0.000179	0.000298	CcSEcCtD
Icosapent ethyl—Oedema—Capecitabine—breast cancer	0.000178	0.000296	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—NOS3—breast cancer	0.000178	0.00079	CbGpPWpGaD
Icosapent ethyl—Infection—Capecitabine—breast cancer	0.000177	0.000294	CcSEcCtD
Icosapent ethyl—Dizziness—Irinotecan—breast cancer	0.000176	0.000293	CcSEcCtD
Icosapent ethyl—Anorexia—Docetaxel—breast cancer	0.000176	0.000292	CcSEcCtD
Icosapent ethyl—Shock—Capecitabine—breast cancer	0.000176	0.000291	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—breast cancer	0.000175	0.000291	CcSEcCtD
Icosapent ethyl—Tachycardia—Capecitabine—breast cancer	0.000174	0.000289	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—breast cancer	0.000174	0.000288	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—breast cancer	0.000173	0.000287	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Capecitabine—breast cancer	0.000173	0.000286	CcSEcCtD
Icosapent ethyl—Body temperature increased—Paclitaxel—breast cancer	0.000172	0.000285	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—breast cancer	0.00017	0.000282	CcSEcCtD
Icosapent ethyl—Anorexia—Capecitabine—breast cancer	0.00017	0.000282	CcSEcCtD
Icosapent ethyl—Vomiting—Irinotecan—breast cancer	0.00017	0.000281	CcSEcCtD
Icosapent ethyl—Vomiting—Mitoxantrone—breast cancer	0.00017	0.000281	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—breast cancer	0.000169	0.000281	CcSEcCtD
Icosapent ethyl—Dizziness—Fluorouracil—breast cancer	0.000169	0.00028	CcSEcCtD
Icosapent ethyl—Rash—Mitoxantrone—breast cancer	0.000168	0.000279	CcSEcCtD
Icosapent ethyl—Rash—Irinotecan—breast cancer	0.000168	0.000279	CcSEcCtD
Icosapent ethyl—Dermatitis—Mitoxantrone—breast cancer	0.000168	0.000279	CcSEcCtD
Icosapent ethyl—Dermatitis—Irinotecan—breast cancer	0.000168	0.000279	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000168	0.000279	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—breast cancer	0.000168	0.000279	CcSEcCtD
Icosapent ethyl—Insomnia—Docetaxel—breast cancer	0.000167	0.000277	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—breast cancer	0.000165	0.000274	CcSEcCtD
Icosapent ethyl—Vomiting—Gemcitabine—breast cancer	0.000165	0.000274	CcSEcCtD
Icosapent ethyl—Dyspnoea—Docetaxel—breast cancer	0.000164	0.000273	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CB—breast cancer	0.000164	0.000729	CbGpPWpGaD
Icosapent ethyl—Rash—Gemcitabine—breast cancer	0.000164	0.000272	CcSEcCtD
Icosapent ethyl—Dermatitis—Gemcitabine—breast cancer	0.000164	0.000272	CcSEcCtD
Icosapent ethyl—Malnutrition—Methotrexate—breast cancer	0.000163	0.00027	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000163	0.00027	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PTGS2—breast cancer	0.000163	0.000722	CbGpPWpGaD
Icosapent ethyl—Vomiting—Fluorouracil—breast cancer	0.000162	0.00027	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—breast cancer	0.000162	0.000269	CcSEcCtD
Icosapent ethyl—Dyspepsia—Docetaxel—breast cancer	0.000162	0.000269	CcSEcCtD
Icosapent ethyl—Insomnia—Capecitabine—breast cancer	0.000161	0.000268	CcSEcCtD
Icosapent ethyl—Rash—Fluorouracil—breast cancer	0.000161	0.000267	CcSEcCtD
Icosapent ethyl—Dermatitis—Fluorouracil—breast cancer	0.000161	0.000267	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—breast cancer	0.000161	0.000267	CcSEcCtD
Icosapent ethyl—Decreased appetite—Docetaxel—breast cancer	0.00016	0.000266	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—breast cancer	0.000159	0.000265	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Docetaxel—breast cancer	0.000159	0.000264	CcSEcCtD
Icosapent ethyl—Dyspnoea—Capecitabine—breast cancer	0.000159	0.000264	CcSEcCtD
Icosapent ethyl—Pain—Docetaxel—breast cancer	0.000158	0.000262	CcSEcCtD
Icosapent ethyl—Constipation—Docetaxel—breast cancer	0.000158	0.000262	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—breast cancer	0.000157	0.000261	CcSEcCtD
Icosapent ethyl—Dyspepsia—Capecitabine—breast cancer	0.000157	0.000261	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—breast cancer	0.000157	0.000261	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—breast cancer	0.000156	0.00026	CcSEcCtD
Icosapent ethyl—Asthenia—Paclitaxel—breast cancer	0.000156	0.000259	CcSEcCtD
Icosapent ethyl—Decreased appetite—Capecitabine—breast cancer	0.000155	0.000258	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—breast cancer	0.000155	0.000257	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Capecitabine—breast cancer	0.000154	0.000256	CcSEcCtD
Icosapent ethyl—Pruritus—Paclitaxel—breast cancer	0.000154	0.000255	CcSEcCtD
Icosapent ethyl—Pain—Capecitabine—breast cancer	0.000153	0.000253	CcSEcCtD
Icosapent ethyl—Constipation—Capecitabine—breast cancer	0.000153	0.000253	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—breast cancer	0.000152	0.000253	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Docetaxel—breast cancer	0.000152	0.000252	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—breast cancer	0.000151	0.000251	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—breast cancer	0.000149	0.000248	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—breast cancer	0.000147	0.000245	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Capecitabine—breast cancer	0.000147	0.000244	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—breast cancer	0.000147	0.000244	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—breast cancer	0.000146	0.000243	CcSEcCtD
Icosapent ethyl—Body temperature increased—Docetaxel—breast cancer	0.000146	0.000242	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—breast cancer	0.000145	0.000241	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—breast cancer	0.000145	0.00024	CcSEcCtD
Icosapent ethyl—Dizziness—Paclitaxel—breast cancer	0.000144	0.000239	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—breast cancer	0.000143	0.000238	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—breast cancer	0.000142	0.000236	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PTEN—breast cancer	0.000142	0.00063	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Epirubicin—breast cancer	0.000141	0.000235	CcSEcCtD
Icosapent ethyl—Body temperature increased—Capecitabine—breast cancer	0.000141	0.000234	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—breast cancer	0.000141	0.000234	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—breast cancer	0.000139	0.00023	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—breast cancer	0.000139	0.00023	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—breast cancer	0.000139	0.00023	CcSEcCtD
Icosapent ethyl—Vomiting—Paclitaxel—breast cancer	0.000138	0.00023	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—breast cancer	0.000138	0.000229	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—breast cancer	0.000137	0.000228	CcSEcCtD
Icosapent ethyl—Rash—Paclitaxel—breast cancer	0.000137	0.000228	CcSEcCtD
Icosapent ethyl—Dermatitis—Paclitaxel—breast cancer	0.000137	0.000227	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—breast cancer	0.000137	0.000227	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—breast cancer	0.000137	0.000227	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—breast cancer	0.000137	0.000227	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—breast cancer	0.000136	0.000226	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—breast cancer	0.000134	0.000222	CcSEcCtD
Icosapent ethyl—Cough—Epirubicin—breast cancer	0.000133	0.000221	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—breast cancer	0.000133	0.000221	CcSEcCtD
Icosapent ethyl—Asthenia—Docetaxel—breast cancer	0.000132	0.00022	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—breast cancer	0.000132	0.000219	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—breast cancer	0.000132	0.000218	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—breast cancer	0.000131	0.000217	CcSEcCtD
Icosapent ethyl—Pruritus—Docetaxel—breast cancer	0.00013	0.000217	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—breast cancer	0.00013	0.000215	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—breast cancer	0.00013	0.000215	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—breast cancer	0.00013	0.000215	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—breast cancer	0.000128	0.000213	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—breast cancer	0.000128	0.000213	CcSEcCtD
Icosapent ethyl—Asthenia—Capecitabine—breast cancer	0.000128	0.000213	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—breast cancer	0.000127	0.000211	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—breast cancer	0.000127	0.000211	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—breast cancer	0.000127	0.00021	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—breast cancer	0.000127	0.00021	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—breast cancer	0.000126	0.00021	CcSEcCtD
Icosapent ethyl—Pruritus—Capecitabine—breast cancer	0.000126	0.00021	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—breast cancer	0.000124	0.000206	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—breast cancer	0.000124	0.000206	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—breast cancer	0.000124	0.000206	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—breast cancer	0.000124	0.000205	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—breast cancer	0.000123	0.000204	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—breast cancer	0.000122	0.000203	CcSEcCtD
Icosapent ethyl—Dizziness—Docetaxel—breast cancer	0.000122	0.000202	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—breast cancer	0.000122	0.000202	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—breast cancer	0.000121	0.000201	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000121	0.000201	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—breast cancer	0.00012	0.0002	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—breast cancer	0.00012	0.000199	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—breast cancer	0.00012	0.000199	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—breast cancer	0.00012	0.000199	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—breast cancer	0.00012	0.000199	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—breast cancer	0.000119	0.000197	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—breast cancer	0.000119	0.000197	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—breast cancer	0.000118	0.000197	CcSEcCtD
Icosapent ethyl—Dizziness—Capecitabine—breast cancer	0.000118	0.000196	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—breast cancer	0.000117	0.000195	CcSEcCtD
Icosapent ethyl—Vomiting—Docetaxel—breast cancer	0.000117	0.000195	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—breast cancer	0.000117	0.000194	CcSEcCtD
Icosapent ethyl—Rash—Docetaxel—breast cancer	0.000116	0.000193	CcSEcCtD
Icosapent ethyl—Dermatitis—Docetaxel—breast cancer	0.000116	0.000193	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—breast cancer	0.000116	0.000192	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—breast cancer	0.000115	0.000191	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—breast cancer	0.000115	0.000191	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—breast cancer	0.000115	0.00019	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—breast cancer	0.000114	0.00019	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—breast cancer	0.000114	0.000189	CcSEcCtD
Icosapent ethyl—Vomiting—Capecitabine—breast cancer	0.000113	0.000188	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000113	0.000188	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—breast cancer	0.000113	0.000188	CcSEcCtD
Icosapent ethyl—Rash—Capecitabine—breast cancer	0.000113	0.000187	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—breast cancer	0.000112	0.000187	CcSEcCtD
Icosapent ethyl—Dermatitis—Capecitabine—breast cancer	0.000112	0.000187	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—breast cancer	0.000112	0.000186	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—breast cancer	0.000111	0.000185	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—breast cancer	0.000111	0.000184	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—breast cancer	0.00011	0.000182	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—breast cancer	0.000109	0.000182	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—breast cancer	0.000109	0.000182	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—breast cancer	0.000108	0.000179	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—breast cancer	0.000107	0.000178	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—breast cancer	0.000106	0.000177	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—breast cancer	0.000106	0.000177	CcSEcCtD
Icosapent ethyl—Body temperature increased—Methotrexate—breast cancer	0.000105	0.000174	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000105	0.000174	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—breast cancer	0.000104	0.000173	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—breast cancer	0.000103	0.00017	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—breast cancer	0.000102	0.00017	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—breast cancer	0.000101	0.000168	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CA—breast cancer	0.0001	0.000444	CbGpPWpGaD
Icosapent ethyl—Decreased appetite—Doxorubicin—breast cancer	0.0001	0.000166	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—breast cancer	9.93e-05	0.000165	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—breast cancer	9.84e-05	0.000163	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—breast cancer	9.84e-05	0.000163	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—breast cancer	9.83e-05	0.000163	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—breast cancer	9.53e-05	0.000158	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—breast cancer	9.48e-05	0.000157	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—breast cancer	9.4e-05	0.000156	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—breast cancer	9.1e-05	0.000151	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—breast cancer	8.92e-05	0.000148	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—breast cancer	8.8e-05	0.000146	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—breast cancer	8.79e-05	0.000146	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—breast cancer	8.45e-05	0.00014	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—breast cancer	8.38e-05	0.000139	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—breast cancer	8.37e-05	0.000139	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—breast cancer	8.25e-05	0.000137	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—breast cancer	8.22e-05	0.000136	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—AKT1—breast cancer	8.17e-05	0.000363	CbGpPWpGaD
Icosapent ethyl—Pruritus—Doxorubicin—breast cancer	8.14e-05	0.000135	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—breast cancer	7.91e-05	0.000131	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—breast cancer	7.84e-05	0.00013	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—breast cancer	7.83e-05	0.00013	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—breast cancer	7.61e-05	0.000126	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—breast cancer	7.32e-05	0.000121	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—breast cancer	7.25e-05	0.00012	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—breast cancer	7.25e-05	0.00012	CcSEcCtD
